The Geneva papers on risk and insurance. Issues and practice最新文献_第3页

Emerging risks and (liability) insurance in the time of pandemics 流行病时期新出现的风险和(责任)保险

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-07-01 DOI: 10.1057/s41288-023-00304-x

I. Ebert, M. Faure, E. Karner

引用次数: 0

The impact of the Russia–Ukraine war on the world’s largest listed insurance firms 俄乌战争对全球最大的上市保险公司的影响

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-06-30 DOI: 10.1057/s41288-023-00305-w

António Miguel Martins, P.F. Correia, R. Gouveia

引用次数: 2

Distant relations: business interruption insurance and business closure insurance. 远亲险:经营中断险、停业险。

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-06-07 DOI: 10.1057/s41288-023-00303-y

Ulrich Stahl

{"title":"Distant relations: business interruption insurance and business closure insurance.","authors":"Ulrich Stahl","doi":"10.1057/s41288-023-00303-y","DOIUrl":"https://doi.org/10.1057/s41288-023-00303-y","url":null,"abstract":"This article looks at COVID-19-related issues in the context of commercial and industrial insurance cover taken out against the risk of infectious disease. The focus is on government action taken and regulation passed in the U.K. and in Germany, respectively, to redress the pandemic. The insurance market offers business interruption (BI) cover (in the U.K. and internationally) as well as business closure (BC) cover (mainly in Germany) to protect against the impact of infectious diseases on commercial enterprises. The insurance law issues that came to be analysed in relation to the COVID-19 pandemic formed the subject matter of widespread litigation in both countries. Judgements were rendered in the Supreme Court in the U.K. (the FCA test case) and in the German Federal Supreme Court and now provide some authoritative legal guidance. However, the outcome of these court battles was totally different, insofar as policyholders were concerned. This article, next to offering some historical legal analysis of BI and BC insurance cover, attempts to explain why policyholders won in court in the U.K. and lost the legal argument in Germany and seeks to reconcile these diverse outcomes. The article ends with a brief outlook on how the pertinent COVID-19 insurance law issues might come to be revisited, both by the markets and in the legal community, in the context of reinsurance coverage.","PeriodicalId":75009,"journal":{"name":"The Geneva papers on risk and insurance. Issues and practice","volume":" ","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2023-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9688068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Providing pandemic business interruption coverage with double trigger cat bonds. 通过双重触发猫债券提供疫情业务中断保险。

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-05-30 DOI: 10.1057/s41288-023-00299-5

André Schmitt, Sandrine Spaeter

{"title":"Providing pandemic business interruption coverage with double trigger cat bonds.","authors":"André Schmitt, Sandrine Spaeter","doi":"10.1057/s41288-023-00299-5","DOIUrl":"10.1057/s41288-023-00299-5","url":null,"abstract":"The aim of this paper is to show how qualified investors in cat bonds can offer adequate pandemic business interruption protection in a comprehensive public-private coverage scheme. First, we propose a numerical model to expose how cat bonds can contribute to complement standard re/insurance by improving coverage of cedents even though risks are positively correlated during a pandemic. Second, we introduce double trigger pandemic business interruption cat bonds, which we name PBI bonds, and discuss their precise characteristics to provide efficient coverage. A first trigger should be pulled when the World Health Organization declares a Public Health Emergency of International Concern (PHEIC). The second trigger determines the payout of the bond based on the modelised business interruption losses of an industry in a country. We discuss moral hazard, basis risk, correlation and liquidity issues which are critical in the context of a pandemic. Third, we simulate the life of theoretical PBI bonds in the restaurant industry in France by using data gathered during the COVID-19 pandemic.","PeriodicalId":75009,"journal":{"name":"The Geneva papers on risk and insurance. Issues and practice","volume":" ","pages":"1-27"},"PeriodicalIF":0.0,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228458/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9711962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Greenfield foreign direct investments and insurance market diversification: a cross-country analysis 绿地外国直接投资与保险市场多元化:一个跨国分析

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-05-22 DOI: 10.1057/s41288-023-00301-0

Bojan Srbinoski, K. Poposki, W. Kwon, K. Denčić-Mihajlov

引用次数: 0

COVID-19 off-label uses of medicines: the role of civil liability and regulation. 新冠肺炎药品标签外使用：民事责任和监管的作用。

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-05-19 DOI: 10.1057/s41288-023-00302-z

Andrea Parziale

{"title":"COVID-19 off-label uses of medicines: the role of civil liability and regulation.","authors":"Andrea Parziale","doi":"10.1057/s41288-023-00302-z","DOIUrl":"10.1057/s41288-023-00302-z","url":null,"abstract":"Physicians can prescribe medicines for different indications than the tested and authorised ones. Such 'off-label' uses expand therapeutic options but also create uncertainties. The COVID-19 pandemic triggered new off-label uses and, despite issues being reported in the literature, these have not resulted in substantial personal injury litigation in the EU. Against this backdrop, this article argues that civil liability plays, in fact, a limited role in off-label uses. In particular, civil liability may incentivise health actors to follow and react to the development of the evidence basis for off-label uses. However, it is ultimately unable to incentivise the conduct of additional research on off-label uses. This is problematic, as off-label research is key to protecting patients and is recommended by international medical ethics. The article concludes by critically discussing proposed mechanisms to incentivise off-label research. It argues that extending civil liability for unknown risks may have undesired effects on insurability and innovation, and most regulatory proposals seem ineffective. Building on the 2014 Italian reform of off-label uses, the article proposes the establishment of a fund financed by mandatory contributions from the industry, which should be used by pharmaceutical regulators to promote off-label research and develop guidelines for prescribers.","PeriodicalId":75009,"journal":{"name":"The Geneva papers on risk and insurance. Issues and practice","volume":" ","pages":"1-18"},"PeriodicalIF":0.0,"publicationDate":"2023-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196280/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9705189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Economic policy uncertainty and directors and officers liability insurance: a perspective on capital market pressures. 经济政策的不确定性与董事和高管责任保险：资本市场压力视角。

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-05-07 DOI: 10.1057/s41288-023-00300-1

Huobao Xie, Can Lin

引用次数: 0

Why banks insure structured commodity trade finance risk: evidence from a worldwide survey 银行为何为结构性商品贸易融资风险投保:来自全球调查的证据

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-04-12 DOI: 10.1057/s41288-023-00296-8

Alexander Braun, Marius Fischer, Csilla Schreiber-Orosz

引用次数: 0

Assessing U.S. insurance firms' climate change impact and response 评估美国保险公司对气候变化的影响和应对

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-04-12 DOI: 10.1057/s41288-023-00297-7

Aparna Gupta, Abena Owusu, Jue Wang

引用次数: 0

English tort law and the pandemic: the dog that has not barked. 英国侵权法与疫情：没有吠叫的狗。

The Geneva papers on risk and insurance. Issues and practice Pub Date : 2023-04-08 DOI: 10.1057/s41288-023-00298-6

David Howarth

引用次数: 0